Professor of the Public Understanding of Risk
Research Interests: Public understanding of uncertainty and risk, Bayesian methods, biostatistics, performance assessment
Examples sheets and lecture notes can be found on my teaching page.
Publications
‘Careless pork costs lives’: Risk stories from science to press release to media
– Health, Risk & Society
(2011)
13,
47
(doi: 10.1080/13698575.2010.540645)
How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?
– Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
(2011)
14,
371
(doi: 10.1016/j.jval.2010.09.001)
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
– Health Technol Assess
(2011)
15,
1
(doi: 10.3310/hta15100)
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
– Health technology assessment (Winchester, England)
(2011)
15,
Quantifying uncertainty
(2011)
17
Barriers to Health Information and Building Solutions
– BETTER DOCTORS, BETTER PATIENTS, BETTER DECISIONS: ENVISIONING HEALTH CARE 2020
(2011)
191
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: A systematic review and economic evaluation
– Health Technology Assessment
(2011)
15,
134
(doi: 10.3310/hta15100)
Modelling bias in combining small area prevalence estimates from multiple surveys.
– Journal of the Royal Statistical Society Series A (Statistics in Society)
(2010)
174,
31
Mathematics and medical statistics
(2010)
921
Designing and implementing sample and data collection for an international genetics study: The Type 1 Diabetes Genetics Consortium (T1DGC)
– Clin Trials
(2010)
7,
5
(doi: 10.1177/1740774509356002)
- <
- 14 of 44